# AI News 180m Report｜2026-09-08 21:00–24:00 JST｜Page 2 of 2

One place for news and notices from 2 countries/regions: Taiwan, 87 items from 4 sources; Japan, 17 items from 1 source.One edition every 180 minutes: every item from every source received in the period, with the original link.

## 華安 (6657) shareholders to participate in 源華智醫’s year 115 cash capital increase; payment call period runs from 9/11 to 10/12 — Global Bio & Investment Monthly

- Published: 2026-09-08T01:00:00+09:00
- Source: Taiwan | 環球生技月刊
- Original: https://news.gbimonthly.com/tw/invest/show.php?num=90041&range=news
- anchor: #n2589255
- Companies mentioned: 華安、源華智醫

## One-year study results for 鼎晉’s long-acting botulinum toxin type A show an adverse event rate of 0.7% — Global Bio & Investment Monthly

- Published: 2026-09-08T01:00:00+09:00
- Source: Taiwan | 環球生技月刊
- Original: https://news.gbimonthly.com/tw/invest/show.php?num=90024
- anchor: #n2589254
- Companies mentioned: 鼎晉生技

Facts:
- The adverse event rate was 0.7%
- The study enrolled 200 participants
- A total of 432 treatment sessions have been completed
- OBI-858, a 760kDa long-acting botulinum toxin type A drug

## The 15th class of ITRI fellows announced; Taipei Veterans General Hospital President Chen Wei-ming selected in recognition of his contributions to medicine — Global Bio & Investment Monthly

- Published: 2026-09-07T01:00:00+09:00
- Source: Taiwan | 環球生技月刊
- Original: https://news.gbimonthly.com/tw/invest/show.php?num=90009
- anchor: #n2589253
- Companies mentioned: 工業技術研究院、台積電、瑞昱半導體、臺北榮民總醫院

Facts:
- 3 newly appointed fellows

## 保瑞’s August revenue hit a historic second-high of NT$2.18 billion, up 59% year on year - Global Bio & Investment

- Published: 2026-09-07T01:00:00+09:00
- Source: Taiwan | 環球生技月刊
- Original: https://news.gbimonthly.com/tw/invest/show.php?num=90008
- anchor: #n2589252
- Companies mentioned: 保瑞藥業、保瑞

Facts:
- Self-reported consolidated revenue for August was NT$2.18 billion
- Year-on-year growth of 59.22%
- Revenue for the first 8 months of this year totaled NT$13.979 billion
- Up 6.09% year over year